Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Blood Test Could Help Bowel Cancer Patients Avoid Drug Side-Effects

March 25, 2015 8:33 am | by University of Manchester | News | Comments

Researchers have provided early evidence to suggest that a blood test could be used to identify bowel cancer patients that may benefit from more intensive chemotherapy. Read more...


Researchers Identify Red Blood Cell Traits Associated with Malaria Risk in Children

March 25, 2015 8:27 am | by NIAID | News | Comments

The findings could help identify future targets for new malaria drugs and vaccines. Read more...


Official: Ebola Survivor May Have Infected New Liberia Case

March 25, 2015 8:21 am | by Jonathan Paye-Layleh, Associated Press | News | Comments

A woman who tested positive for Ebola in Liberia last week is dating a survivor of the disease. Read more...


Potential for ALS Treatment Found in Three Proteins

March 25, 2015 8:17 am | by David Callahan, KTH Royal Institute of Technology | News | Comments

Recent research at Sweden's KTH Royal Institute of Technology has found three proteins that could shed some light on the mechanisms behind ALS. Read more...


Study of Thousands of Brains Reveals Tau as Driver of Alzheimer's

March 24, 2015 12:58 pm | by Mayo Clinic | News | Comments

By examining more than 3,600 postmortem brains, researchers at Mayo Clinic's campuses in Jacksonville, Florida, and Rochester, Minnesota, have found that the progression of dysfunctional tau protein drives the cognitive decline and memory loss seen in Alzheimer's disease. Read more...


Nanotechnology Platform Shows Promise for Treating Pancreatic Cancer

March 24, 2015 12:48 pm | by UCLA | News | Comments

Scientists at UCLA’s California NanoSystems Institute and Jonsson Comprehensive Cancer Center have combined their nanotechnology expertise to create a new treatment that may solve some of the problems of using chemotherapy to treat pancreatic cancer. Read more...


Pfizer, Lilly To Resume Phase 3 Chronic Pain Program For Tanezumab

March 24, 2015 12:37 pm | News | Comments

Pfizer Inc. and Eli Lilly and Company announced that they are preparing to resume the Phase 3 clinical program for tanezumab. Read more...


Bristol-Myers Acquires Novo License for Autoimmune Diseases Research Program

March 24, 2015 12:33 pm | News | Comments

Bristol-Myers Squibb Company announced the company has signed an agreement with Novo Nordisk under which Bristol-Myers Squibb will acquire an exclusive global license to a discovery biologics research program focused on modulating the innate immune system as a therapy for autoimmune diseases. Read more...


Enzyme that Helps Prevent Anemia: Discovery

March 24, 2015 12:19 pm | by Scripps Research Institute | News | Comments

​Stem cells can generate any type of cell in the body, but they are inactive most of the time—and for good reason. When stem cells become too active and divide too often, they risk acquiring cell damage and mutations. Read more...


Gilead Issues Safety Alert over Hepatitis C, Heart Drug Combination

March 24, 2015 12:03 pm | by Ryan Bushey, Associate Editor | Articles | Comments

Taking these medications together is ill-advised.


Cipher Pharmaceuticals Acquires Canadian Rights to Novel Psoriasis, Rheumatoid Arthritis Treatment

March 24, 2015 8:54 am | News | Comments

Approximately 500,000 in Canada people receive treatment for psoriasis. Read more...


Blood Thinning Drug Aids Understanding of Natural HIV Barrier

March 24, 2015 8:50 am | by University of East Anglia | News | Comments

A blood thinning agent is helping researchers understand more about the body’s natural barriers to HIV. Read more...


Scientists Use DNA Sequencing to Trace Spread of Drug Resistant TB

March 24, 2015 8:45 am | by Sam Wong, Imperial College London | News | Comments

Scientists have for the first time used DNA sequencing to trace the fatal spread of multidrug-resistant tuberculosis between patients in the UK. Read more...


WHO Denies Politics Swayed Ebola Emergency Declaration

March 24, 2015 8:40 am | by Maria Cheng and Raphael Satter, Associated Press | News | Comments

The World Health Organization denied Monday that politics swayed the decision to declare an international emergency over the spread of the Ebola virus last year. Read more...


Neovacs Launches American Subsidiary in Boston

March 24, 2015 8:36 am | News | Comments

Neovacs will be located in Boston within the French Tech Hub. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.